How are CYP1A2 and Darmgesundheit related?

The relationship between CYP1A2 and gut health is indirect and primarily mediated through metabolism of dietary compounds. CYP1A2 is a liver enzyme that metabolizes caffeine, aryl amine carcinogens, and certain phytochemicals. Some of these substrates or their metabolites may influence gut barrier function, immune responses, or microbiome composition. For instance, high CYP1A2 activity might promote formation of reactive metabolites from heterocyclic amines, potentially contributing to gut inflammation. However, direct human evidence linking CYP1A2 genotype or activity to clinically meaningful gut health outcomes is weak and mostly mechanistic. Individual enzyme activity is strongly modulated by smoking, diet, and genetics (e.g., rs762551). Without specific blood or stool markers, the connection remains speculative. Caveat: No clinical recommendation for gut health can be derived from CYP1A2 genotype alone.